Prevalence of Nephrolithiasis in Patients with Chronic Liver Disease: A Case-Control Study

J Clin Exp Hepatol. 2018 Dec;8(4):375-379. doi: 10.1016/j.jceh.2018.01.004. Epub 2018 Feb 11.

Abstract

Background and aims: Nephrolithiasis is known to be associated with several systemic diseases including chronic kidney disease and renal failure, which can also occur as a complication of chronic liver disease (CLD). This study aimed to assess the prevalence of nephrolithiasis in patients with CLD.

Methods: A short survey was completed by 198 patients with CLD and 322 controls matched by age, sex, and state of residence. A primary diagnosis of liver disease was confirmed with health record review.

Results: The median age of the liver disease group was 63 years and 128 (65%) were male; the median age of the control group was 63 and 199 (63%) were male. Body mass index was higher in the liver disease group (27.8 vs 26.7, P < .01). The most common liver disease diagnosis was hepatitis C (60 [30%]) followed by alcoholic cirrhosis (42 [21.2%]). The self-reported prevalence of nephrolithiasis in the liver disease group was 26%, compared to 14% in the control group (P < .01). This association remained significant after adjusting for age, sex, body mass index, and family history of kidney stones or liver disease.

Conclusions: In this case-control, survey-based study, the prevalence of nephrolithiasis was 2 times higher in patients with CLD.

Keywords: BMI, Body Mass Index; CLD, Chronic Liver Disease; NASH, Nonalcoholic Steatohepatitis; NL, Nephrolithiasis; OR, Odds Ratio; hepatic failure; steatohepatitis; urolithiasis.